Stocktoria
BIOLIFE SOLUTIONS INC BLFS
Nasdaq · XNAS · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 1989-11-22
BIOLIFE SOLUTIONS INC statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 64.6% | 67.1% | 60.7% | — | — |
| Operating margin | -17.3% | -6.0% | -25.3% | -7.8% | -29.5% |
| Net margin | -4.8% | -27.0% | -100.0% | -183.4% | -7.5% |
| FCF margin | 11.1% | 7.0% | -27.8% | -24.8% | -10.9% |
| Return on assets | -1.1% | -5.1% | -16.5% | -31.1% | -1.6% |
| Return on equity | -1.2% | -5.8% | -20.1% | -38.4% | -1.9% |
| Debt / equity | 0.01× | 0.05× | 0.07× | 0.07× | 0.02× |
| Current ratio | 5.94 | 4.54 | 2.86 | 3.11 | 2.95 |
| Revenue growth | 28.9% | 9.7% | -10.8% | -36.0% | 147.8% |
Source: SEC EDGAR filings · CIK 0000834365 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.